graphpad prism v.9.0.1 (GraphPad Software Inc)
90
Structured Review
GraphPad Software Inc
graphpad prism v.9.0.1
Graphpad Prism V.9.0.1, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/graphpad+prism+v%2E9%2E0%2E1/graphpad+prism+software/pm40490072-66-5-8
Average 90 stars, based on 1 article reviews
Graphpad Prism V.9.0.1, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/graphpad+prism+v%2E9%2E0%2E1/graphpad+prism+software/pm40490072-66-5-8
Average 90 stars, based on 1 article reviews
graphpad prism v.9.0.1 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Software:Article Title: Cerebral blood flow and cerebrovascular reactivity are modified by maturational stage and exercise training status during youth Article Snippet: Monoexponential modelling with a delay term was then used to explore the onset response of ICAQ to Article Title: A four-point molecular handover during Okazaki maturation. Article Snippet: Protein band intensities were quantified using ImageJ83 and then plotted against fraction numbers using Article Title: miRNAs as potential biomarkers for subclinical atherosclerosis in Sjögren’s disease Article Snippet: Figures were created using Article Title: Qualification of a flow cytometry-based method for the evaluation of in vitro cytotoxicity of GTA002 natural killer cell therapy Article Snippet: Article Title: Stable colonization of the model kissing bug Rhodnius prolixus by Trypanosoma cruzi Y strain. Article Snippet: Data were graphed using Article Title: Weight gain and metabolic disturbances in people living with HIV who start antiretroviral therapy with, or switch to, bictegravir/emtricitabine/tenofovir alafenamide after 48 weeks of treatment: A real-world prospective study. Article Snippet: Background: People living with HIV (PLWH) starting or switching to an integrase strand transfer inhibitor-based regimen are more likely to experience weight gain than other classes of antiretroviral regimens.. The aim of this study was to evaluate the weight gain and metabolic disturbances in PLWHwho start antiretroviral therapy (ART) with bictegravir/emtricitabine/ tenofovir alafenamide and in individuals who switch from another ART to BIC/FTC/TAF after 48 weeks.. Methods: A prospective longitudinal study was conducted in an HIV clinic in Mexico. Article Title: From Past to Present: A Bibliometric and Visualized Study of the Most Impactful Publications on Congenital Diaphragmatic Hernia (CDH). Article Snippet: Statistical analysis was performed with Article Title: Obesity Enables NLRP3 Activation and Induces Myocardial Fibrosis via Hyperacetylation of HADHa. Article Snippet: All statistical analyses were performed with |